1 Min Read
Feb 7 (Reuters) - AstraZeneca Plc:
* BRILINTA SIGNIFICANTLY REDUCES CV EVENTS AND CORONARY DEATH BEYOND ONE YEAR IN HEART ATTACK SURVIVORS WITH MULTI-VESSEL DISEASE Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.